Matteo Libero Baroni
Project Manager- Gene and Cell Therapy at Remora Biotech- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Native or bilingual proficiency
-
French Professional working proficiency
-
Spanish Full professional proficiency
-
Swedish Limited working proficiency
-
Italian Native or bilingual proficiency
-
Catalan Limited working proficiency
Topline Score
Bio
Credentials
-
DiaNa communication training
Uppsala UniversityJan, 2016- Nov, 2024 -
General Proficency English
UNSWFeb, 2009- Nov, 2024
Experience
-
Remora Biotech
-
Switzerland
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Project Manager- Gene and Cell Therapy
-
Nov 2021 - Present
Establish and maintain expertise in all relevant pre-clinical and clinical data in the Gene and Cell therapy arena. Extrapolate clinical dynamics and patterns in the broader market and provide recommendations on findings regarding experimental, clinical and marketing trends. Support data generation, analysis, and dissemination to relevant stake holders. Product and business development activities. Establish and maintain expertise in all relevant pre-clinical and clinical data in the Gene and Cell therapy arena. Extrapolate clinical dynamics and patterns in the broader market and provide recommendations on findings regarding experimental, clinical and marketing trends. Support data generation, analysis, and dissemination to relevant stake holders. Product and business development activities.
-
-
-
Fundación Josep Carreras contra la Leucemia
-
Spain
-
Non-profit Organizations
-
1 - 100 Employee
-
PhD Candidate
-
Sep 2016 - Sep 2020
Development of novel CAR T-cell therapies for the treatment of relapsed and chemo-refractory Acute Leukemias.Co-authored 6 high-impact factors studies (Q1 journals). Supervised interns and students on the latest techniques of genetic engineering. Attended, as a speaker, international conferences and scientific workshops. Development of novel CAR T-cell therapies for the treatment of relapsed and chemo-refractory Acute Leukemias.Co-authored 6 high-impact factors studies (Q1 journals). Supervised interns and students on the latest techniques of genetic engineering. Attended, as a speaker, international conferences and scientific workshops.
-
-
-
Uppsala University
-
Sweden
-
Higher Education
-
700 & Above Employee
-
Research Assistant
-
Jan 2015 - Jun 2016
Quantitatively described the mechanism of action of translation-targeting antibiotics. Artificially engineered termination factors to study their role in bacterial replication. Designed artificial DNA and RNA constructs for experimental purposes. Identified suitable techniques for data collection and analysis. Quantitatively described the mechanism of action of translation-targeting antibiotics. Artificially engineered termination factors to study their role in bacterial replication. Designed artificial DNA and RNA constructs for experimental purposes. Identified suitable techniques for data collection and analysis.
-
-
-
Uppsala University
-
Sweden
-
Higher Education
-
700 & Above Employee
-
Bachelor degree project
-
Oct 2013 - Jan 2014
Uppsala Biomedical centre, department of Neuroscience.By the use of RNAi, this study aimed to investigate the role in metabolism and behavior of obesity-linked genes in D.melanogaster. Uppsala Biomedical centre, department of Neuroscience.By the use of RNAi, this study aimed to investigate the role in metabolism and behavior of obesity-linked genes in D.melanogaster.
-
-
Education
-
2016 - 2020
Universitat de Barcelona
Doctor of Philosophy - PhD, Biomedicine (Specialization Immuno-Oncology) -
2014 - 2016
Uppsala University
Master of Science (MSc), Cell and Molecular Biology -
2010 - 2014
Uppsala University
Bachelor of Science - BSc, Biology and Chemistry -
2008 - 2009
UNSW
General Proficiency English, English Language and Literature/Letters
Community
